SAI Life Sciences

company

About

SAI Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions.

  • 1001 - 5000

Details

Last Funding Type
Series D
Industries
Health Care,Pharmaceutical
Founded date
Jan 1, 1999
Number Of Employee
1001 - 5000
Operating Status
Active

SAI is an ideal drug discovery, development and manufacturing partner. Their pharma and biotech clients gain clear competitive advantages through shorter time to market and risk minimization using their integrated and high-quality scientific services.

SAI’s mission is to help their partners develop innovative medicines quicker and at lower cost by providing reliable research and manufacturing solutions. Their guiding principles are to be reliable, communicate effectively, safeguard IP, invest in people and to adopt technologies.

At SAI Life Sciences, developing a business relationship with their clients that benefits both parties is only the beginning. They have learned through experience, it is when they build a partnership with a customer, that they can truly amplify their mutual interests and successes. At SAI they will call this “+1” and it hints at the additional value they aim to find mutually in longer term relationships.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
SAI Life Sciences has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jul 27, 2018 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 27, 2018 Series D 1 TPG Detail
Jul 25, 2018 Private Equity(PE) 1 TPG Detail

Investors

Number of Lead Investors
Number of Investors
2
1
SAI Life Sciences is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG Yes Series D